资讯

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.
Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...
In today’s world, losing weight isn’t just about fitting into your old jeans—it’s about reclaiming your energy, confidence, ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
Glucagon-like peptide-1 (GLP-1) injections such as Wegovy (semaglutide) and Zepbound (tirzepatide) are the most effective weight-loss medications available today. Oral GLP-1 pills, such as ...
Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...
These popular medications are now at the center of a major weight loss drug lawsuit. Find out which drugs and involved and ...
The World Health Organization continues its investigation into the origins of COVID-19, with significant information still needed. Concurrently, Americans like Amy Spencer are crafting their own ...
The WHO continues to probe COVID-19 origins, yet critical information is lacking. Meanwhile, individuals like Amy Spencer are ...
Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...